Structures by: Anderson C. J.
Total: 11
C23H36ClCuN5O8
C23H36ClCuN5O8
Journal of medicinal chemistry (2007) 50, 10 2527-2535
a=21.134(4)Å b=10.7258(16)Å c=23.111(4)Å
α=90.00° β=90.00° γ=90.00°
C16H28N4O4Cu,ClO4,Na,3(H2O)
C16H28N4O4Cu,ClO4,Na,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=8.0242(5)Å b=9.3141(6)Å c=15.3597(10)Å
α=96.6070(10)° β=97.3590(10)° γ=92.5420(10)°
C18H38Cl2CuN4O14
C18H38Cl2CuN4O14
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=8.7623(5)Å b=17.9633(10)Å c=17.2184(10)Å
α=90.00° β=93.2180(10)° γ=90.00°
C37H70Cl3Cu2N8Na3O21
C37H70Cl3Cu2N8Na3O21
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=15.6342(17)Å b=34.587(4)Å c=9.4238(10)Å
α=90.00° β=90.00° γ=90.00°
C19H37ClCuN4O9
C19H37ClCuN4O9
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=27.6657(19)Å b=7.9539(6)Å c=10.7296(7)Å
α=90.00° β=90.00° γ=90.00°
C15H40CuN4O10.5P
C15H40CuN4O10.5P
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 1938-1950
a=10.1989(19)Å b=35.067(7)Å c=12.943(3)Å
α=90.00° β=90.00° γ=90.00°
C14H33N4O6P2,4(H2O),Cl
C14H33N4O6P2,4(H2O),Cl
Dalton Transactions (2010) 39, 7 1699-1701
a=11.5219(16)Å b=11.7468(16)Å c=9.6554(13)Å
α=90.00° β=115.254(3)° γ=90.00°
C14H38Cl0.5CuN4Na0.5O10P2
C14H38Cl0.5CuN4Na0.5O10P2
Dalton Transactions (2010) 39, 7 1699-1701
a=9.5428(5)Å b=15.5173(7)Å c=16.9240(10)Å
α=80.039(4)° β=81.081(4)° γ=89.874(3)°
C29H21Cl2CuN5O10S2
C29H21Cl2CuN5O10S2
Inorganic Chemistry (2007) 46, 2417-2426
a=15.8162(2)Å b=12.9136(2)Å c=16.8236(2)Å
α=90.00° β=114.0750(10)° γ=90.00°
C59H42Cu2F12N10O2P2S4
C59H42Cu2F12N10O2P2S4
Inorganic Chemistry (2007) 46, 2417-2426
a=18.7741(8)Å b=19.6516(8)Å c=17.3283(8)Å
α=90.00° β=115.311(2)° γ=90.00°
C56H36.63B3Cu2F12N8O0.25S4
C56H36.63B3Cu2F12N8O0.25S4
Inorganic Chemistry (2007) 46, 2417-2426
a=27.2491(6)Å b=18.7615(5)Å c=24.5663(6)Å
α=90.00° β=121.9390(10)° γ=90.00°